MICROCAPS ADARE
Dead / Abandoned — International registration dead — extension of protection cancelled (as of 11 Nov 2025)
What this means for you
This application is over — abandoned 11 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79386527
- Mark type
- Design + words
- Filed
- 21 Jul 2023
- Abandoned
- 11 Nov 2025
- Attorney of record
- ROBERT S. BRODER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, veterinary and sanitary products, namely, drug delivery agents in the form of specialized tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, filled capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines and injectables used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, bronchoconstriction, thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, Alzheimer's, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis; inhalers for medical purposes sold filled with pharmaceutical, veterinary and sanitary preparations for treating asthma, pulmonary hypertension, inflammation of respiratory tract, bronchoconstriction, plasmodium infections and fungal infections
- Class 040 — Treatment of materials: Manufacturing services to the order and specification of others of drug dosage forms, drug compositions, drug formulations, drug delivery agents in the nature of tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines, injectables, aerosols, and sanitary products, all in the pharmaceutical and the veterinary fields; clinical manufacturing of drug compositions for others to support clinical trials
- Class 042 — Scientific and technological services: Research and development services in the pharmaceutical and the veterinary fields; product design and development of pharmaceutical preparations including powder and granules for suspension in liquids, semisolid forms, solid forms, capsules, tablets, sachets, sprinkles; research and development in the area of drug delivery systems with customized release, taste masked release, controlled release; technological consultancy services in the field of new product development
Owner
Prior registrations
Prosecution history
- 30 Nov 2025 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 30 Nov 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 23 Oct 2025 — EXPARTE APPEAL TERMINATED
- 23 Oct 2025 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 23 Oct 2025 — ABANDONMENT - EXPRESS MAILED
- 22 Oct 2025 — TEAS EXPRESS ABANDONMENT RECEIVED
- 13 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 May 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 May 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 12 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 May 2025 — NON-FINAL ACTION E-MAILED
- 12 May 2025 — NON-FINAL ACTION WRITTEN
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Apr 2025 — ASSIGNED TO LIE